| Se Chang, CAA | |
|
110 Irving St Nw, Washington, DC 20010-3017 | |
| (703) 969-7309 | |
| Not Available |
| Full Name | Se Chang |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology Assistant |
| Experience | 4 Years |
| Location | 110 Irving St Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609400233 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | AA000129 (* (Not Available)) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medstar Georgetown University Hospital | Washington, DC | Hospital |
| Medstar Washington Hospital Center | Washington, DC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medstar Medical Group Anesthesiology Llc | 1052678034 | 456 |
News Archive
Gastric cancer is a major cause of cancer deaths in the world. The outcome of large gastric tumors and those with lymph node involvement remains poor after surgical resection. The optimal adjuvant therapy after surgical resection remains to be determined.
The Monash University Institute of Pharmaceutical Sciences today announced positive results from a first-in-human study of a new, inhaled form of a medicine that could significantly reduce maternal deaths around the world.
A team of international scientists led by Dr. Michael Jarvis at the University of Plymouth has received funding in excess of £408,000 from Innovate UK to develop a new and economic vaccine designed to halt the spread of highly pathogenic 'zoonotic' (spreading from animals to humans) infectious diseases.
BrainScope Company, Inc. announced today that it is preparing for the introduction of the Ahead™ EU-100, a product in development to aid in the assessment of head injury, in the United Kingdom.
› Verified 3 days ago
| Entity Name | Medstar Medical Group Anesthesiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528578333 PECOS PAC ID: 1052678034 Enrollment ID: O20171129001837 |
News Archive
Gastric cancer is a major cause of cancer deaths in the world. The outcome of large gastric tumors and those with lymph node involvement remains poor after surgical resection. The optimal adjuvant therapy after surgical resection remains to be determined.
The Monash University Institute of Pharmaceutical Sciences today announced positive results from a first-in-human study of a new, inhaled form of a medicine that could significantly reduce maternal deaths around the world.
A team of international scientists led by Dr. Michael Jarvis at the University of Plymouth has received funding in excess of £408,000 from Innovate UK to develop a new and economic vaccine designed to halt the spread of highly pathogenic 'zoonotic' (spreading from animals to humans) infectious diseases.
BrainScope Company, Inc. announced today that it is preparing for the introduction of the Ahead™ EU-100, a product in development to aid in the assessment of head injury, in the United Kingdom.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Se Chang, CAA 4931 Sauquoit Ln, Annandale, VA 22003-5100 Ph: (703) 969-7309 | Se Chang, CAA 110 Irving St Nw, Washington, DC 20010-3017 Ph: (703) 969-7309 |
News Archive
Gastric cancer is a major cause of cancer deaths in the world. The outcome of large gastric tumors and those with lymph node involvement remains poor after surgical resection. The optimal adjuvant therapy after surgical resection remains to be determined.
The Monash University Institute of Pharmaceutical Sciences today announced positive results from a first-in-human study of a new, inhaled form of a medicine that could significantly reduce maternal deaths around the world.
A team of international scientists led by Dr. Michael Jarvis at the University of Plymouth has received funding in excess of £408,000 from Innovate UK to develop a new and economic vaccine designed to halt the spread of highly pathogenic 'zoonotic' (spreading from animals to humans) infectious diseases.
BrainScope Company, Inc. announced today that it is preparing for the introduction of the Ahead™ EU-100, a product in development to aid in the assessment of head injury, in the United Kingdom.
› Verified 3 days ago
Alexandra Megan Fine, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-7000 | |
Alexa Aramini, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-3303 | |
Shelby Fullen, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-7000 | |
Domenic Derobertis, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1150 Varnum St Ne, Washington, DC 20017 Phone: 202-854-7000 | |
Timothy Olukanni, Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 900 23rd St Nw, Washington, DC 20037 Phone: 202-715-4000 | |
Kanchanish Kaur, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-9418 | |
Elizabeth Stephenson, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-7000 |